Dual-action approach combining 5-HT4R Agonist (SPC-15) and NMDAR antagonist demonstrates enhanced efficacy in preclinical study for managing severe conditions The […]

AUSTIN, Texas, Nov. 18, 2024 (GLOBE NEWSWIRE) — Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a leader in enterprise […]

FLORHAM PARK, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, […]

Ms. Nassif brings an extensive track record of successfully developing commercial strategies for multiple FDA-approved drugs Appointment initiates Cassava’s commercial […]

Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. […]

BOCA RATON, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (NASDAQ: NEWT) announced today that its national bank subsidiary, […]

HAUPPAUGE, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of […]

KISSIMMEE, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (Nasdaq: ECDA) (“ECA Auto Design” or the “Company”), […]